A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2011
03/17/2011	US20110065742 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high PH environments
03/17/2011	US20110065741 Methods for treating irritable bowel syndrome (ibs)
03/17/2011	US20110065740 Methods of treating travelers diarrhea and hepatic encephalopathy
03/17/2011	US20110065739 Novel isoxazole drivative
03/17/2011	US20110065738 Polycyclic guanine derivatives and use thereof
03/17/2011	US20110065737 Hcv protease inhibitors
03/17/2011	US20110065736 Quinazoline derivatives as vegf inhibitors
03/17/2011	US20110065735 Substituted quinazolines
03/17/2011	US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
03/17/2011	US20110065733 Mapk/erk kinase inhibitors
03/17/2011	US20110065732 Kit for topical application of medication
03/17/2011	US20110065731 Uses of dpp-iv inhibitors
03/17/2011	US20110065730 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
03/17/2011	US20110065729 Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/17/2011	US20110065728 Lipoprotein lipase-activating compositions comprising benzene derivatives
03/17/2011	US20110065727 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/17/2011	US20110065726 Organic Compounds
03/17/2011	US20110065725 Triazole amide derivatives for use in therapy
03/17/2011	US20110065724 Compounds that modulate intracellular calcium
03/17/2011	US20110065723 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]-n-[3-(4-pyridyl)-1-[2-(4-pyridyl)ethyl]propyl]propanamide and uses thereof
03/17/2011	US20110065722 A crystalline form of posaconazole
03/17/2011	US20110065721 Metaxalone products, method of manufacture, and method of use
03/17/2011	US20110065720 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
03/17/2011	US20110065719 Pharmaceutical formulations containing flavouring substances with improved pharmaceutical
03/17/2011	US20110065718 Antifungal Product, Use and Formulation Thereof
03/17/2011	US20110065717 Sulfoximine derivatives as factor xa inhibitors
03/17/2011	US20110065716 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/17/2011	US20110065715 Nogo Receptor Binding Small Molecules to Promote Axonal Growth
03/17/2011	US20110065714 Substituted quinazolines
03/17/2011	US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors
03/17/2011	US20110065712 Tricyclic compounds and pharmaceutical uses thereof
03/17/2011	US20110065711 Substituted triazolo-pyridazine derivatives
03/17/2011	US20110065710 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives
03/17/2011	US20110065709 Aurora kinase modulators and method of use
03/17/2011	US20110065708 Heterocyclic oxime compounds
03/17/2011	US20110065707 New hsl inhibitors useful in the treatment of diabetes
03/17/2011	US20110065706 Therapeutic Agents 812
03/17/2011	US20110065705 Compositions and Methods of Treating Cell Proliferation Disorders
03/17/2011	US20110065704 Compounds for modulating rna binding proteins and uses therefor
03/17/2011	US20110065703 Novel agents of calcium ion channel modulators
03/17/2011	US20110065702 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
03/17/2011	US20110065701 Pharmaceutical compounds
03/17/2011	US20110065700 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/17/2011	US20110065699 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/17/2011	US20110065698 Novel protein kinase modulators
03/17/2011	US20110065697 2-oxy-benzoxazinone derivatives for the treatment of obesity
03/17/2011	US20110065696 Imidazoyl pyridine compounds and salts thereof
03/17/2011	US20110065695 Use of aminodihydrothiazines for the treatment or prevention of diabetes
03/17/2011	US20110065694 Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof
03/17/2011	US20110065693 Therapeutic pyrazoloquinoline derivatives
03/17/2011	US20110065692 Therapeutic pyrazolonaphthyridine derivatives
03/17/2011	US20110065691 Therapeutic piperazines
03/17/2011	US20110065690 Compositions and methods for treatment of leukemia
03/17/2011	US20110065689 Therapeutic piperazines
03/17/2011	US20110065688 Therapeutic piperazines
03/17/2011	US20110065687 Hydrazide compounds and uses thereof
03/17/2011	US20110065686 Chemical compounds having antiviral activity against dengue virus and other flaviviruses
03/17/2011	US20110065685 Novel indoles are cannabinoid receptor ligands
03/17/2011	US20110065684 Phthalazine derivatives as parp inhibitors
03/17/2011	US20110065683 Trisubstituted pyrazoles as acetylcholine receptor modulators
03/17/2011	US20110065682 Heterocyclic compounds as factor ixa inhibitors
03/17/2011	US20110065681 Amide compounds, compositions and uses thereof
03/17/2011	US20110065680 Metal Complexes
03/17/2011	US20110065679 Substituted Porphyrins
03/17/2011	US20110065678 Isoxazolidine derivatives
03/17/2011	US20110065677 Methods of Treating Inflammation with Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastrointestinal Tract and Providing Enhanced Therapeutic Activity
03/17/2011	US20110065676 Combination therapies comprising par1 antagonists with nar agonists
03/17/2011	US20110065675 Azo dye related small molecule modulators of protein-protein interactions
03/17/2011	US20110065674 Methods and compositions for improving cognitive function
03/17/2011	US20110065673 Novel leukotriene receptor agonist
03/17/2011	US20110065672 Bisphosphonate-prostatic acid phosphatase inhibitor conjugates to treat prostate cancer bone metastasis
03/17/2011	US20110065671 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
03/17/2011	US20110065670 Skin Beautifier
03/17/2011	US20110065669 Oxazolobenzimidazole derivatives
03/17/2011	US20110065668 Phenylpyrazole derivatives
03/17/2011	US20110065667 Phenylpyrazole derivatives
03/17/2011	US20110065666 Method of producing a bran product
03/17/2011	US20110065665 Stabilization of vitamin b12
03/17/2011	US20110065664 Kinase protein binding inhibitors
03/17/2011	US20110065663 Anti-cancer combination therapy
03/17/2011	US20110065662 Compounds, Compositions, and Methods for Protecting Brain Health in Neurodegenerative Disorders
03/17/2011	US20110065661 Pharmacoperones for correcting disease states involving protein misfolding
03/17/2011	US20110065660 Chemosensory Receptor Ligand-Based Therapies
03/17/2011	US20110065659 Protopanaxadiol-type ginsenoside compositions and uses thereof
03/17/2011	US20110065658 Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same
03/17/2011	US20110065657 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
03/17/2011	US20110065656 Dopaminergic mimetics
03/17/2011	US20110065655 Therapeutic composition to treat lesions caused by herpes simplex virus
03/17/2011	US20110065651 Heterocyclic substituted piperazines with cxcr3 antagonist activity
03/17/2011	US20110065650 Methods of Inhibiting Tumor Cell Proliferation
03/17/2011	US20110065645 Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance
03/17/2011	US20110065644 Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
03/17/2011	US20110065638 Novel crustacean androgenic gland hormone
03/17/2011	US20110065637 Method to reduce SLOSH energy absorption and its damaging effects through the reduction of inelastic collisions in an organism
03/17/2011	US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)
03/17/2011	US20110065634 Glucagon receptor antagonists, compositions, and methods for their use
03/17/2011	US20110065631 Process for preparation of hiv protease inhibitors
03/17/2011	US20110065629 Enteral nutrient
03/17/2011	US20110065628 Medication Combinations for the Treatment of Alcoholism and Drug Addiction
03/17/2011	US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes

1 ... 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 ... 7860